Home › Animal Bites › NCT05856539
ESP Block in MIS Lumbar Spine Surgery
Recruiting
Erector Spinae Plane Block in Patients Undergoing Minimally Invasive Lumbar Spine Surgery: A Randomized Controlled Trial
Who can join
Ages 18 to 80 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 18-80 * Patients scheduled for MIS TLIF (any level) with the principal investigator * ASA 1, 2, 3 Exclusion Criteria: * ASA 4 or higher * BMI \>40 * Chronic opioid use (daily use for \> 3 months) * Revision surgery, any history of previous lumbar spine surgery * Allergy to any of the study medications * Non-English speaking * Chronic renal insufficiency or failure (creatinine \>2) or severe hepatic disease (cirrhosis, failure) * Pregnancy * Any concomitant surgery
About the study
This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.
What is being tested
- Erector spinae plane (ESP) block (procedure)
Sponsor: Hospital for Special Surgery, New York · Participants: 48 · Started: May 15, 2023
Contact the study team
- Sheeraz Qureshi, MD, MBA · Phone: 919-260-9699
Official record on ClinicalTrials.gov — NCT05856539
Locations in the U.S.
| New York | Hospital for Special Surgery, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.